Back to Suzhou BioMedic, all the IPs that BIOHLDG that will be injecting into consists of immunity-boosting, obesity-care, anti-ageing, longevity as well as β-nicotinamide mononucleotide or NMN supplement. A study by Frost and Sullivan indicates that the market size for antidiabetic treatment in China is expected to grow with 12.2% CAGR from 2018 to 2027, where the HRT market in China is expected to grow with 4.6% CAGR from 2020 to 2027.
We do not know any guidance on the future earnings yet, but assuming the JV could contribute 50% of what Bioalpha Hainan is doing on a minimum case scenario, that would mean an additional revenue contribution of RM8.2 million per quarter and RM32.8 million per financial year. A conservative net profit margin of 12% would result in an increase of RM3.9 million in net profit and when translated to market capitalization with the 5-year average PER of 22.8 times, it is expected to add RM86.6 million to the market capitalization or 7.3 cents per share.
Unfortunately, due to the bad market condition, BIOHLDG’s price could not reflect its true value. Personally, I think BIOHLDG is worth at least 27 ~ 28 cents in value. We shall wait for the market to rebound and determine market’s assumption on the company valuation.
Actually from the article above, we can see that bholding is doing the best to transform their company to more strong fundamental based. Instead of goreng, I guess they want to convert their business to a long run structure.
Suzhou MedicalSystem had connections with approximately 80% of China’s triple-A Grade hospitals.
For the investment savvies, the JV will require a total initial capex of RMB5.0 million, which RMB4.05 million will be coming from BIOHLDG and the rest to be paid by Suzhou MedicalSystem. This would translate to an 81% stake in the Suzhou BioMedic. Apart from that, the company would also inject Intellectual Properties (IPs) into the Suzhou Biomedic including formulations that aid Type 2 Diabetes and for those who are undergoing Hormone Replacement Therapy (HRT) as well.
In this case, I think work in both way la. Now warrant wanna expire, sure will have another wave of goreng la. Bio pattern when come with news, got chance to spike high.
Plus additional that all previous contract not fully reflect in QR which I think if sooner or later profit, the share price will like rocket aldi (Disclaimer : not a buy call, just personal opinion)
New IPO: Carlo Rino Group Berhad, a leading fashion retailer of women’s handbags, footwear, and accessories, aims to list on the ACE Market!
MQ Trader 126 views | 22 h ago
0:17
New IPO: A homegrown air fragrance company, Vanzo Holdings Berhad aims to list on the Ace Market!
MQ Trader 234 views | 1 d ago
0:17
New IPO: Winstar Capital Berhad, a specialist in the extrusion of aluminium profiles and fabrication of aluminium ladders aims to list on the ACE Market!
MQ Trader 403 views | 2 d ago
0:17
New IPO: Topvision Eye Specialist Berhad, specializing in medical eye care services aims to list on the ACE Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
limyeesee
35 posts
Posted by limyeesee > 2021-09-23 11:59 | Report Abuse
如果不能长期持有就做短期, 像bioholding 这种,可以借趋势购买的